• An Outsourcing Future Of Information Sharing And Commercial Streamlining

    Outsourced Pharma Chief Editor Louis Garguilo writes about what outsourcing professionals think about the future of working with CDMOs.

  • Your Consultants, Your Destiny

    Have consultants become more important than ever in pharma manufacturing? Louis Garguilo, Chief Editor, Outsourced Pharma, talks with three experts who have strong opinions on this question.

  • Is Technology The New Science Of Outsourcing?

    That’s the abstruse thought with which I left the 2023 CDMO Leadership Awards ceremony in Manhattan. I’ve subsequently tried to sort this out by referring back to a series of interviews I did with CDMO leaders at the event. I think now I can explain this to readers. 

  • Gene Therapy Developer Rocket Pharma Aims High

    “From our first patient until now, all our manufactured drug product that has treated patients has been produced in partnership with CDMOs,” says Gaurav Shah, M.D., cofounder and CEO of Rocket Pharma.

  • A Real Celebration Of The Best CDMOs

    This annual issue presenting our readers with the best-of-the-best CDMOs is once again accompanied by a live celebration in Manhattan. However, in two ways the 2023 Awards differ from those of the past.

  • A More Balanced And Stable Future With CDMOs

    Two Industry Experts talk about where they see the outsourcing industry going in the near future.

  • Safe At Home With Generics

    “I have not wanted to go to India or China for most of my API needs, and to the extent possible I do not want to go there for formulations either,” is part of a surprising sentiment from a long-tenured generics outsourcing professional.  

  • The Hardest Job In All BioPharma: The CTO

    CTO roles have expanded, deepened, and pressurized – particularly at drug sponsors reliant on outsourcing development and manufacturing capabilities. Now CTOs are actively seeking ways to improve their leadership skills so they can better handle the transforming environment.

  • We’ve Moved Forward

    In addition to our annual CMO Leadership awards, what you’ll read in these pages is the importance of continuing to advance the knowledge, best practices, and strategies of outsourcing we’ve been covering now for nearly a decade in this issue.

  • Outsourcing From A To ZZ Biotech

    Kent Pryor, CEO of ZZ Biotech, explains how he’s approached his single-handed “CEO As Outsourcer” role and provides advice to professionals of all positions in any biopharma organization.


Louis Garguilo

Louis Garguilo is chief editor of Outsourced Pharma, and is considered a leading authority on the art and science of drug development and manufacturing outsourcing. He studied public relations and journalism at Syracuse University (and holds a Master’s in English). His widely read editorials are based on in-depth analysis and interviews with industry executives and professionals. Editorials are written in an engaging and unique style that guide readers through the macro aspects and subtle nuances of outsourcing, and working with contract development and manufacturing organizations (CDMOs). Garguilo also serves as moderator for the various Outsourced Pharma Live webinars held throughout the year.

Prior to joining Outsourced Pharma in 2014, Garguilo spent a decade at a global pharmaceutical contract research, development and manufacturing organization, leaving the industry after attaining the role of vice president, business development and marketing. Additionally, he has served under the governor of New York in the state’s economic development agency, as liaison to the pharmaceutical/biotechnology industry; as chief strategic officer for an e-learning software company; and spent most of the ‘80s and ‘90s in Japan as an educator, author, and communications consultant.